Oruen CNS Weekly Roundup: Latest Findings Across CNS Medicine
Alzheimer’s Disease
Estrogen-based menopausal hormone therapy linked to lower Alzheimer’s pathology
A Stanford-led study found that estrogen-based menopausal hormone therapy was associated with lower levels of Alzheimer’s-related neuropathology. The findings add to ongoing research examining how hormone exposure may influence Alzheimer’s risk and brain ageing.
Movement Disorders / Parkinson’s Disease
Researchers uncover how alpha-synuclein damages neurons in Parkinson’s disease
University of Oxford researchers have identified a mechanism through which pathological alpha-synuclein interferes with an important cellular process in neurons. The discovery provides further insight into how Parkinson’s-associated protein pathology damages brain cells and could reveal targets for future disease-modifying treatments.
Epilepsy / Artificial Intelligence
AI detects subtle signatures of epilepsy in brain-wave recordings
University of Delaware researchers are using artificial intelligence to identify patterns within EEG recordings associated with epilepsy. The approach could eventually support more objective detection of epilepsy-related brain activity, particularly when conventional EEG interpretation is inconclusive.
Hyperlink:
https://www.udel.edu/udaily/2026/august/decoding-epilepsy-in-brain-waves/
Stroke / Neuroimaging
Automated MRI system could strengthen preclinical stroke research
Researchers have developed an automated MRI analysis system designed to standardise measurements of brain injury in experimental stroke research. Improving consistency between laboratories could make it easier to assess potential therapies and reproduce findings across different research centres.
Hyperlink:
https://www.eurekalert.org/news-releases/1139924
Sleep Disorders / Alzheimer’s Disease
Sleep duration associated with Alzheimer’s disease pathology and cognition
Research highlighted by the European Academy of Neurology examines associations between sleep duration, Alzheimer’s disease biomarkers and cognitive performance. The findings contribute to growing evidence that sleep characteristics may be closely connected with neurodegenerative processes and long-term cognitive health.
Movement Disorders / Neuromodulation
Non-invasive brain stimulation investigated for Parkinson’s non-motor symptoms
Research examining non-invasive brain stimulation suggests neuromodulation may have potential benefits beyond the motor manifestations of Parkinson’s disease. The findings support further investigation into whether brain stimulation could complement conventional treatment for difficult-to-manage non-motor symptoms.
Hyperlink:
https://medicalxpress.com/news/2026-08-noninvasive-brain-parkinson-nonmotor-symptoms.html
Chronic Pain / Biomarkers
Researchers investigate an objective molecular signature of chronic pain
A new research programme is combining biosensing technologies with neurological measurements to investigate whether chronic pain produces a reproducible molecular signature. Objective biomarkers could eventually complement patient-reported measures and improve diagnosis, treatment selection and clinical-trial assessment.
Neurodegeneration / Brain Ageing
Molecular mechanism may help explain the ageing brain’s vulnerability to disease
Researchers have identified a molecular mechanism that could help explain why ageing increases susceptibility to neurological disease. Understanding the biological relationship between cellular ageing and neurodegeneration could reveal new opportunities for treatments aimed at preserving brain health later in life.
Hyperlink:
https://www.sciencedaily.com/releases/2026/08/260802223433.htm
0 Comments